openPR Logo
Press release

Global Monoclonal Antibody Diagnostic Reagents Sales Market - Industry Analysis, Trends, and Forecast Report 2017

05-22-2017 03:20 PM CET | Health & Medicine

Press release from: Healthcare Market Research Report

Healthcare Market Research Report

Healthcare Market Research Report

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2017” to its report offerings. The report split global into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Monoclonal Antibody Diagnostic Reagents for these regions, from 2012 to 2022 (forecast).

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1067636

In this report, the global Monoclonal Antibody Diagnostic Reagents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Monoclonal Antibody Diagnostic Reagents for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Monoclonal Antibody Diagnostic Reagents market competition by top manufacturers/players, with Monoclonal Antibody Diagnostic Reagents sales volume, Price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
KHB
Leadman
BioSino
Chemclin
Wantai BioPharm
Rongsheng
...

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
Enzyme Linked Immunosorbent assays
Dot-immuogold Filtration Assay
Double Antigen Sandwich Chemiluminescence Method
Recombinant immunoblot assay

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Monoclonal Antibody Diagnostic Reagents for each application, including
Tumor Monitoring
Venereal Disease Diagnosis
Virus Hepatitis Diagnosis
Others
Table of Contents:

Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2017
1 Monoclonal Antibody Diagnostic Reagents Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Diagnostic Reagents
1.2 Classification of Monoclonal Antibody Diagnostic Reagents by Product Category
1.2.1 Global Monoclonal Antibody Diagnostic Reagents Market Size (Sales) Comparison by Type (2012-2022)
2 Global Monoclonal Antibody Diagnostic Reagents Competition by Players/Suppliers, Type and Application
2.1 Global Monoclonal Antibody Diagnostic Reagents Market Competition by Players/Suppliers
2.1.1 Global Monoclonal Antibody Diagnostic Reagents Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Monoclonal Antibody Diagnostic Reagents (Volume and Value) by Type
2.2.1 Global Monoclonal Antibody Diagnostic Reagents Sales and Market Share by Type (2012-2017)
2.2.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Market Share by Type (2012-2017)
3 United States Monoclonal Antibody Diagnostic Reagents (Volume, Value and Sales Price)
3.1 United States Monoclonal Antibody Diagnostic Reagents Sales and Value (2012-2017)
3.1.1 United States Monoclonal Antibody Diagnostic Reagents Sales and Growth Rate (2012-2017)
3.1.2 United States Monoclonal Antibody Diagnostic Reagents Revenue and Growth Rate (2012-2017)
3.1.3 United States Monoclonal Antibody Diagnostic Reagents Sales Price Trend (2012-2017)
3.2 United States Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Players
3.3 United States Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Type
3.4 United States Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Application

4 China Monoclonal Antibody Diagnostic Reagents (Volume, Value and Sales Price)
4.1 China Monoclonal Antibody Diagnostic Reagents Sales and Value (2012-2017)
4.1.1 China Monoclonal Antibody Diagnostic Reagents Sales and Growth Rate (2012-2017)
4.1.2 China Monoclonal Antibody Diagnostic Reagents Revenue and Growth Rate (2012-2017)
4.1.3 China Monoclonal Antibody Diagnostic Reagents Sales Price Trend (2012-2017)
4.2 China Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Players
4.3 China Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Type
4.4 China Monoclonal Antibody Diagnostic Reagents Sales Volume and Market Share by Application

5 Europe Monoclonal Antibody Diagnostic Reagents (Volume, Value and Sales Price)
5.1 Europe Monoclonal Antibody Diagnostic Reagents Sales and Value (2012-2017)
5.1.1 Europe Monoclonal Antibody Diagnostic Reagents Sales and Growth Rate (2012-2017)
5.1.2 Europe Monoclonal Antibody Diagnostic Reagents Revenue and Growth Rate (2012-2017)

Read Full Report with TOC: http://www.marketresearchhub.com/report/global-monoclonal-antibody-diagnostic-reagents-sales-market-report-2017-report.html

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub
LinkedIn: https://www.linkedin.com/company/market-research-hub
Facebook: https://www.facebook.com/MarketResearchHub/

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Monoclonal Antibody Diagnostic Reagents Sales Market - Industry Analysis, Trends, and Forecast Report 2017 here

News-ID: 545140 • Views:

More Releases from Healthcare Market Research Report

Advanced Technologies of Global ICT Investment Trends in Healthcare Market 2017| CenturyLink, Adobe, Dell, Cisco, Google, AT&T, Apple, Informatica, EMC, Microsoft
Advanced Technologies of Global ICT Investment Trends in Healthcare Market 2017| …
Researchmoz added Most up-to-date research on "ICT Investment Trends in Healthcare: Breakthroughs in medical technology nurturing ICT investments" to its huge collection of research reports. ICT Investment Trends in Healthcare: Breakthroughs in medical technology nurturing ICT investments Summary "ICT Investment Trends in Healthcare", report presents the findings from a survey of 189 healthcare providers regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how healthcare providers currently allocate their
Global Anterior Chamber Market Size, Trends, Analysis and Forecast during 2018 - …
An up-to-date research report 2018 has been disclosed by Market Research Hub highlighting the title “Global Anterior Chamber Market Report 2018” which provides an outlook for current market value as well as the expected forecast including Rate on Investment (ROI) together with the growing CAGR near XX% during 2018-2025. The report studies the anterior chamber market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production,
Global Pre-Clinicals Stage Cardiovascular Pipeline Products Market Research and Forecast Report 2022
Global Pre-Clinicals Stage Cardiovascular Pipeline Products Market Research and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Pre-Clinicals Stage Cardiovascular Pipeline Products Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pre-Clinicals Stage Cardiovascular Pipeline Products in these regions, from 2012 to 2022. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220162 The global Pre-Clinicals Stage Cardiovascular Pipeline Products
Global Neurological Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast Report 2022
Global Neurological Biomarkers Market - Industry Analysis, Size, Share, Growth, …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Neurological Biomarkers Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neurological Biomarkers in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220158 The global Neurological Biomarkers market is valued at USD XX million in

All 5 Releases


More Releases for Monoclonal

Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity